DNA damage response induced by exposure of human lung adenocarcinoma cells to smoke from tobacco- and nicotine-free cigarettes.
Cigarette smoke (CS) is the major cause of lung cancer and contributes to the development of other malignancies. Attempts have been made to construct reduced toxicity cigarettes, presumed to have diminished genotoxic potential. One such product on the market is the tobacco and nicotine free (T&N-free) cigarette type made from lettuce and herbal extracts. We have recently developed a sensitive assay of the genotoxicity of CS based on cytometric analysis of induction of the DNA damage response (DDR) in normal human pulmonary endothelial or A549 pulmonary adenocarcinoma cells. In the present study, we observed that exposure of A549 cells to CS from T/N-free cigarettes induced a smoke-dose dependent DDR as evidenced by phosphorylation (activation) of the Ataxia telangiectasia mutated (ATM) protein kinase and of the histone H2AX (γH2AX). The extent of DDR induced by T&N-free smoke was distinctly greater than that induced by comparable doses of CS from reference cigarettes (2R4F) containing tobacco and nicotine. The pattern of DDR induced by T&N-free smoke was similar to that of 2R4F cigarettes in terms of the cell cycle phase specificity and involvement of reactive oxygen species (ROS). The data also imply that similar to 2R4F exposure of cells to T/N-free smoke leads to formation of double-strand DNA breaks (DSBs) resulting from collapse of replication forks upon collision with the primary ssDNA lesions induced by smoke. Since DSBs are potentially carcinogenic our data indicate that smoking tobacco and nicotine-free cigarettes is at least as hazardous as smoking cigarettes containing tobacco and nicotine.
Jorgensen
Ellen D
ED
Brander Cancer Research Institute and Department of Pathology, New York Medical College, Valhalla, NY, USA.
Zhao
Hong
H
Traganos
Frank
F
Albino
Anthony P
AP
Darzynkiewicz
Zbigniew
Z
D000230:Adenocarcinoma / Q000378:metabolism* / Q000473:pathology; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins / Q000378:metabolism; D002460:Cell Line; D053903:DNA Breaks, Double-Stranded; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000378:metabolism; D016193:G1 Phase; D006657:Histones / Q000378:metabolism; D006801:Humans; D008175:Lung Neoplasms / Q000378:metabolism* / Q000473:pathology; D009152:Mutagenicity Tests; D009538:Nicotine / Q000633:toxicity; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism; D017382:Reactive Oxygen Species / Q000378:metabolism; D016196:S Phase; D012906:Smoke; D025521:Tumor Suppressor Proteins / Q000378:metabolism; D014026:Nicotiana
D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D006657:Histones; D017382:Reactive Oxygen Species; D012906:Smoke; D025521:Tumor Suppressor Proteins; D009538:Nicotine; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases
Cell Cycle. 2006 Aug;5(15):1669-74
16861926
Int J Oncol. 2006 Jun;28(6):1491-505
16685450
Exp Cell Res. 1999 May 25;249(1):1-12
10328948
Cell Cycle. 2009 Dec 15;8(24):4112-8
19946210
Cell Cycle. 2008 Dec;7(23):3653-8
19029795
Science. 2005 Apr 22;308(5721):551-4
15790808
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):693-8
15767351
Cytometry A. 2009 Oct;75(10):840-7
19658174
Methods Mol Biol. 2006;319:165-92
16719355
Cell Cycle. 2009 Dec 15;8(24):4067-71
19923893
Leukemia. 2010 Apr;24(4):679-86
20130602
Int J Oncol. 2006 Aug;29(2):495-501
16820894
J Natl Cancer Inst. 2004 Jan 21;96(2):99-106
14734699
Nat Rev Cancer. 2008 Dec;8(12):957-67
19005492
BMJ. 2004 Jan 10;328(7431):72
14715602
Nat Rev Mol Cell Biol. 2000 Dec;1(3):179-86
11252893
Cell Prolif. 2007 Feb;40(1):1-13
17227291
Mutat Res. 1999 Mar 8;424(1-2):9-21
10064846
Cytometry A. 2010 Mar;77(3):285-93
20014310
Cell Cycle. 2005 Jun;4(6):737-40
15908798
Cell Cycle. 2006 Sep;5(17):1940-5
16940754
Mutat Res. 2009 Aug;678(1):43-52
19591958
Cell Cycle. 2006 Nov;5(22):2671-5
17106266
Nat Rev Cancer. 2003 Oct;3(10):733-44
14570033
Cytometry A. 2007 Nov;71(11):905-14
17879239
Addiction. 2006 Oct;101(10):1516-22
16968354
Cell Cycle. 2010 Jan 15;9(2):389-97
20046100
J Intern Med. 2002 Sep;252(3):206-24
12270001
J Natl Cancer Inst. 1998 Oct 7;90(19):1486-8
9776415
Cell Cycle. 2009 Dec;8(23):3810-1
19887905
Cell. 2004 Jul 9;118(1):9-17
15242640
Photochem Photobiol Sci. 2002 Apr;1(4):225-36
12661961
BMC Cell Biol. 2007 Jun 26;8:26
17594478
Cell Cycle. 2009 Jul 15;8(14):2233-7
19502789
Tob Control. 2002 Mar;11 Suppl 1:I40-50
11893814
Cytometry A. 2006 Apr;69(4):212-21
16528719
Cell Cycle. 2005 Oct;4(10):1373-6
16205111
Cell Cycle. 2004 Aug;3(8):1062-8
15254392
Cell Cycle. 2008 May 15;7(10):1490-5
18418078
J Biol Chem. 2001 Nov 9;276(45):42462-7
11571274
Science. 2005 Apr 22;308(5721):510-1
15845843
Cell Cycle. 2007 Apr 15;6(8):931-42
17457059
Cell Cycle. 2005 Feb;4(2):339-45
15655354
J Biol Chem. 2005 Jan 14;280(2):1186-92
15533933
Toxicology. 2002 Dec 27;181-182:219-22
12505314